Recall Alert: Al-Safa US LLC Issues Warning for Listeria Contaminated Frozen Chicken Products

Recall Alert: Al-Safa US LLC Issues Warning for Listeria Contaminated Frozen Chicken Products
Recall Alert: Al-Safa US LLC Issues Warning for Listeria Contaminated Frozen Chicken Products

Al-Safa US LLC, based in Mississauga, Ontario, Canada, is recalling about 2,010 pounds of frozen ready-to-eat chicken products because they might have Listeria bacteria. The recall affects products imported into the United States and was prompted by routine testing by the USDA’s Food Safety and Inspection Service (FSIS).

Testing showed potential Listeria contamination in chicken products made in Canada on June 5, 2024, and brought into the U.S. later in June 2024.

The recalled products include specific batches packaged under the brands “Al Safa Halal Charcoal Grilled Chicken Seekh Kebab Grilled, Minced, Chicken Patty Kebab” and “Al Safa Halal Fully Cooked Chicken Chapli Kebab Seasoned Chicken Patty.”

Each package bears the establishment number “866” within the Canadian mark of inspection, alongside the dates “NOV 30 25” and specific batch identifiers.

Recall Alert: Al-Safa US LLC Issues Warning for Listeria Contaminated Frozen Chicken Products
Recall Alert: Al-Safa US LLC Issues Warning for Listeria Contaminated Frozen Chicken Products

While there have been no confirmed reports of illnesses linked to these products, FSIS urges consumers who have purchased them not to consume them. Instead, the products should either be discarded or returned to the place of purchase. This caution extends to products potentially stored in consumers’ freezers.

Listeria monocytogenes contamination can cause listeriosis, a serious infection that primarily affects older adults, individuals with weakened immune systems, pregnant women, and newborns. Symptoms of listeriosis include fever, muscle aches, headache, stiff neck, confusion, loss of balance, and in severe cases, convulsions.

In pregnant women, listeriosis can lead to miscarriages, stillbirths, premature delivery, or life-threatening infections in newborns. Treatment typically involves antibiotics, and anyone experiencing symptoms within two months of consuming the recalled products should seek medical attention and notify their healthcare provider of the potential exposure.

FSIS continues to monitor the situation closely to ensure that all potentially contaminated products are removed from the market and that consumers are properly informed about the risks associated with these products.

Published
Categorized as News

Leave a comment

Your email address will not be published. Required fields are marked *